Siberian-mouse-hd-154-msh2-003 Instant

Researchers have used the Siberian Mouse HD 154 to investigate the mechanisms underlying the MMR system's function and how it relates to cancer development. The mouse model has also been used to test potential therapeutic strategies for HNPCC and other cancers associated with MSH2 mutations.

The Siberian Mouse HD 154 was first discovered in a remote region of Siberia, where a team of researchers from the Russian Academy of Sciences was conducting a genetic study on local rodent populations. The team, led by renowned geneticist Dr. Natalia Korolkova, was searching for genetic variations that could provide insights into human diseases. siberian-mouse-hd-154-msh2-003

Upon analyzing the genetic material of the Siberian Mouse HD 154, the researchers stumbled upon a peculiar mutation in the MSH2 gene. Further investigation revealed that this mutation, designated as MSH2-003, resulted in a significant decrease in the MMR system's efficiency. Researchers have used the Siberian Mouse HD 154